Lanosterol
Lanosterol is an intermediate of cholesterol synthesis and use of lanosterol induces ubiquitination and degradation of a rate-controlling enzyme of cholesterol synthesis, i.e., HMG CoA reductase. Lanosterol suppresses the aggregation and cytotoxicity of misfolded proteins linked with neurodegenerative diseases[1][2].
Product Specifications
CAS Number
[79-63-0]
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Lanosterol.html
Purity
99.97
Solubility
Ethanol : 10 mg/mL (ultrasonic)
Smiles
C[C@]12C3=C(CC[C@@]1([C@]([C@H](C)CC/C=C(C)/C)([H])CC2)C)[C@@]4([C@@](C(C)([C@@H](O)CC4)C)([H])CC3)C
Molecular Formula
C30H50O
Molecular Weight
426.72
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NFYB (Nuclear Transcription Factor Y Subunit beta, CAAT Box DNA-binding Protein Subunit B, Nuclear Transcription Factor Y Subunit B, NF-YB, HAP3) (FITC)
NFYB (Nuclear Transcription Factor Y Subunit beta, CAAT Box DNA-binding Protein Subunit B, Nuclear Transcription Factor Y Subunit B, NF-YB, HAP3) (FITC)
